Return on Sales (ROS) is a vital financial metric that measures a company's operational efficiency by assessing how effectively it converts revenue into profit. This article explores the calculation of ROS, its significance in financial analysis, its applications in comparing company performance over time and within industries, and its inherent limitations. Understanding ROS is crucial for investors, creditors, and management seeking insights into a company's financial health and operational effectiveness.

Commerce is the structured exchange of goods and services, linking producers and consumers. This article delves into its historical evolution, distinguishing it from broader business activities and trade. It explores how commerce is regulated by national and international bodies to ensure fair practices and economic growth. The piece also highlights the transformative impact of e-commerce, which has broadened market access for businesses of all sizes, making global transactions more accessible and efficient.

European airlines are significantly reducing flight schedules, cutting thousands of flights, as the ongoing conflict in the Middle East drives up jet fuel prices. The aviation industry, particularly in Europe, which relies heavily on Middle Eastern fuel imports, is grappling with the economic fallout, leading to potential widespread disruptions for travelers during peak season.

Meta is set to implement a substantial 10% workforce reduction, impacting approximately 8,000 employees and freezing 6,000 open positions. This decision, aimed at enhancing efficiency and offsetting major investments in AI, comes amidst a strategic shift away from the Metaverse and significant legal battles concerning its platforms' impact on young users. The company is navigating a complex period of restructuring and intensified scrutiny.

The Food and Drug Administration has granted approval for the inaugural gene therapy aimed at restoring hearing in individuals born with specific forms of deafness. This monumental decision, while initially targeting a rare genetic condition, marks a significant stride in the ongoing efforts to combat hearing loss and opens new avenues for therapeutic interventions.